Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Supportive Care in Cancer
Erschienen in: Supportive Care in Cancer 4/2015

01.04.2015 | Original Article

Association between the duration of palliative care service and survival in terminal cancer patients

verfasst von: Yong Joo Lee, Jung-Hwa Yang, Jung-Wook Lee, Johi Yoon, Jung-Ran Nah, Whan-Seok Choi, Chul-min Kim

Erschienen in: Supportive Care in Cancer | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Preliminary studies of early palliative care showed improved quality of life, less medical cost, and better survival time. But, most terminal cancer patients tend to be referred to palliative care late. For the proper care of terminal cancer patients, it is necessary to refer to hospice and palliative care timely. The aim of this study is to analyze the effect of the duration of palliative care services on the survival in terminal cancer patients.

Methods

We reviewed 609 patients who had died from terminal cancer between January 2010 and December 2012. We analyzed correlations of age, first Palliative Performance Scale (PPS) level, duration of palliative care service, and survival time. The Cox proportional hazards regression model was used for both univariate and multivariate analyses of survival.

Results

Duration of palliative care services was significantly correlated with survival time. In univariate Cox regression analysis, age, and each group of duration of palliative care service showed significant associations with survival. Final multivariate Cox regression model retained four parameters as independent prognostic factors for survival (age HR = 0.99 (p = 0.002), 1∼10 days HR = 2.64 (p < 0.001), 11∼30 days HR = 2.43 (p < 0.001), 31∼90 days HR = 1.87 (p < 0.001)).

Conclusions

Shorter duration of palliative care services showed poor prognostic factor. Timely referral system from the end of chemotherapy is warranted.
Literatur
1.
Connor SR, Tecca M, LundPerson J, Teno J (2004) Measuring hospice care: the national hospice and palliative care organization national hospice data set. J Pain Symptom Manag 28:316–328CrossRef
2.
Henriksen HT, Riis J, Leikersfeldt G (2002) Terminally ill cancer patients at home. Experiences with a hospice-based palliative care. Ugeskr Laeger 164:465–467PubMed
3.
Hui D, De La Cruz M, Mori M et al (2013) Concepts and definitions for “supportive care,” “best supportive care,” “palliative care,” and “hospice care” in the published literature, dictionaries, and textbooks. Support Care Cancer 21:659–685CrossRefPubMedCentralPubMed
4.
Lamers WM Jr (2002) Defining hospice and palliative care: some further thoughts. J Pain Palliat Care Pharmacother 16:65–71PubMed
5.
Teitelbaum HS, Travis LD, Heilig DL et al (2013) The epidemiology of hospice and palliative care. Dis Mon 59:309–324CrossRefPubMed
6.
Ventafridda V (2006) According to the 2002 WHO definition of palliative care. Palliat Med 20:159CrossRefPubMed
7.
Bakitas M, Lyons KD, Hegel MT et al (2009) Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the project ENABLE II randomized controlled trial. JAMA 302:741–749CrossRefPubMedCentralPubMed
8.
Brennan F (2013) Holistic Palliative Care approach—physical, spiritual, religious and psychological needs. Nephrology (Carlton)
9.
Armes J, Crowe M, Colbourne L et al (2009) Patients’ supportive care needs beyond the end of cancer treatment: a prospective, longitudinal survey. J Clin Oncol 27:6172–6179CrossRefPubMed
10.
Lidstone V, Butters E, Seed PT, Sinnott C, Beynon T, Richards M (2003) Symptoms and concerns amongst cancer outpatients: identifying the need for specialist palliative care. Palliat Med 17:588–595CrossRefPubMed
11.
Barbera L, Seow H, Howell D et al (2010) Symptom burden and performance status in a population-based cohort of ambulatory cancer patients. Cancer 116:5767–5776CrossRefPubMed
12.
Zimmermann C, Riechelmann R, Krzyzanowska M, Rodin G, Tannock I (2008) Effectiveness of specialized palliative care: a systematic review. JAMA 299:1698–1709CrossRefPubMed
13.
Batchelor NH (2010) Palliative or hospice care? Understanding the similarities and differences. Rehabil Nurs 35:60–64CrossRefPubMed
14.
15.
Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733–742CrossRefPubMed
16.
Bandieri E, Sichetti D, Romero M et al (2012) Impact of early access to a palliative/supportive care intervention on pain management in patients with cancer. Ann Oncol 23:2016–2020CrossRefPubMed
17.
Yoong J, Park ER, Greer JA et al (2013) Early palliative care in advanced lung cancer: a qualitative study. JAMA Intern Med 173:283–290CrossRefPubMed
18.
Lowery WJ, Lowery AW, Barnett JC et al. (2013) Cost-effectiveness of early palliative care intervention in recurrent platinum-resistant ovarian cancer. Gynecol Oncol
19.
Spiro SG, Rudd RM, Souhami RL et al (2004) Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life. Thorax 59:828–836CrossRefPubMedCentralPubMed
20.
Baek YJ, Shin DW, Choi JY et al (2011) Late referral to palliative care services in Korea. J Pain Symptom Manag 41:692–699CrossRef
21.
Greer JA, Jackson VA, Meier DE, Temel JS (2013) Early integration of palliative care services with standard oncology care for patients with advanced cancer. CA Cancer J Clin
22.
Davidoff AJ, Tang M, Seal B, Edelman MJ (2010) Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol 28:2191–2197CrossRefPubMed
23.
Zhang YD, Yang Q, Jiang ZM, Ma W, Zhou SW, Xie DR (2011) Overall survival of patients with advanced pancreatic cancer improved with an increase in second-line chemotherapy after gemcitabine-based therapy. JOP 12:131–137PubMed
24.
Tzioras S, Pavlidis N, Paraskevaidis E, Ioannidis JP (2007) Effects of different chemotherapy regimens on survival for advanced cervical cancer: systematic review and meta-analysis. Cancer Treat Rev 33:24–38CrossRefPubMed
25.
Chen XZ, Yang K, Liu J, Chen XL, Hu JK (2011) Neoadjuvant plus adjuvant chemotherapy benefits overall survival of locally advanced gastric cancer. World J Gastroenterol 17:4542–4544CrossRefPubMedCentralPubMed
26.
Wright AA, Zhang B, Keating NL, Weeks JC, Prigerson HG (2014) Associations between palliative chemotherapy and adult cancer patients’ end of life care and place of death: prospective cohort study. BMJ 348:g1219CrossRefPubMedCentralPubMed
27.
Keam B, Oh DY, Lee SH et al (2008) Aggressiveness of cancer-care near the end-of-life in Korea. Jpn J Clin Oncol 38:381–386CrossRefPubMed
28.
Anderson F, Downing GM, Hill J, Casorso L, Lerch N (1996) Palliative performance scale (PPS): a new tool. J Palliat Care 12:5–11PubMed
29.
Hui D, Kim SH, Roquemore J, Dev R, Chisholm G, Bruera E (2014) Impact of timing and setting of palliative care referral on quality of end-of-life care in cancer patients. Cancer 120:1743–1749CrossRefPubMed
30.
Le BH, Mileshkin L, Doan K et al (2014) Acceptability of early integration of palliative care in patients with incurable lung cancer. J Palliat Med 17:553–558CrossRefPubMed
31.
Schockett ER, Teno JM, Miller SC, Stuart B (2005) Late referral to hospice and bereaved family member perception of quality of end-of-life care. J Pain Symptom Manag 30:400–407CrossRef
32.
Lee YJ, Suh SY, Choi YS et al (2014) EORTC QLQ-C15-PAL quality of life score as a prognostic indicator of survival in patients with far advanced cancer. Support Care Cancer 22:1941–1948CrossRefPubMed
33.
Choi JY, Shin DW, Kang J et al (2012) Variations in process and outcome in inpatient palliative care services in Korea. Support Care Cancer 20:539–547CrossRefPubMed
34.
Morita T, Akechi T, Ikenaga M et al (2005) Late referrals to specialized palliative care service in Japan. J Clin Oncol 23:2637–2644CrossRefPubMed
35.
Morita T, Miyashita M, Tsuneto S, Sato K, Shima Y (2009) Late referrals to palliative care units in Japan: nationwide follow-up survey and effects of palliative care team involvement after the cancer control act. J Pain Symptom Manag 38:191–196CrossRef
36.
Sanz Ortiz J (2012) Chemotherapy at the end of life: up until when? Clin Transl Oncol 14:667–674CrossRefPubMed
37.
Randen M, Helde-Frankling M, Runesdotter S, Strang P (2013) Treatment decisions and discontinuation of palliative chemotherapy near the end-of-life, in relation to socioeconomic variables. Acta Oncol 52:1062–1066CrossRefPubMed
38.
Yun YH, Kwak M, Park SM et al (2007) Chemotherapy use and associated factors among cancer patients near the end of life. Oncology 72:164–171CrossRefPubMed
39.
Follwell M, Burman D, Le LW et al (2009) Phase II study of an outpatient palliative care intervention in patients with metastatic cancer. J Clin Oncol 27:206–213CrossRefPubMed
40.
Greer JA, Jackson VA, Meier DE, Temel JS (2013) Early integration of palliative care services with standard oncology care for patients with advanced cancer. CA Cancer J Clin 63:349–363CrossRefPubMed
41.
Yennurajalingam S, Atkinson B, Masterson J et al (2012) The impact of an outpatient palliative care consultation on symptom burden in advanced prostate cancer patients. J Palliat Med 15:20–24CrossRefPubMed
42.
Amadori D, Tassinari D, Maltoni M (2005) Palliative care in advanced cancer. Minerva Chir 60:205–216PubMed
43.
Ferrell B, Levy MH, Paice J (2008) Managing pain from advanced cancer in the palliative care setting. Clin J Oncol Nurs 12:575–581CrossRefPubMed
44.
Greer JA, Pirl WF, Jackson VA et al (2012) Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer. J Clin Oncol 30:394–400CrossRefPubMed
45.
Cheng WW, Willey J, Palmer JL, Zhang T, Bruera E (2005) Interval between palliative care referral and death among patients treated at a comprehensive cancer center. J Palliat Med 8:1025–1032CrossRefPubMed
Metadaten
Titel
Association between the duration of palliative care service and survival in terminal cancer patients
verfasst von
Yong Joo Lee
Jung-Hwa Yang
Jung-Wook Lee
Johi Yoon
Jung-Ran Nah
Whan-Seok Choi
Chul-min Kim
Publikationsdatum
01.04.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 4/2015
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-014-2444-4

Weitere Artikel der Ausgabe 4/2015

Supportive Care in Cancer 4/2015 Zur Ausgabe

Original Article

Identifying clinical and support service resources and network practices for cancer patients and survivors in southern Puerto Rico

Original Article

Sleep disturbance in cancer patients and caregivers who contact telephone-based help services

Original Article

The impact of hospice care on survival and cost saving among patients with liver cancer: a national longitudinal population-based study in Taiwan

Original Article

Readmission rates due to venous thromboembolism in cancer patients after abdominopelvic surgery, a retrospective chart review

Original Article

Dietary habits changes and quality of life in patients undergoing chemotherapy for epithelial ovarian cancer

Original Article

Therapeutic and preventive antiemetic effect of aprepitant in Japanese patients with thoracic malignancies who truly need it

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

23.04.2024 Medikamente in Schwangerschaft und Stillzeit Nachrichten

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise